- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about LGVN
Recent news which mentions LGVN
Earnings Scheduled For November 12, 2021
November 12, 2021
From Benzinga
5 Cheap Stocks Set to Double This Month
November 02, 2021
From InvestorPlace
7 Penny Stocks to Buy to Sidestep the Noise on Wall Street
October 21, 2021
From InvestorPlace
2 Moonshot Stocks Insiders Have Suddenly Started Buying
October 15, 2021
From InvestorPlace
3 Penny Stocks Insiders Are Buying
October 15, 2021
From Benzinga
2 Penny Stocks Insiders Are Buying
October 13, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 04, 2021
From Benzinga
Longeveron Successfully Advancing its Cell-Based Therapy Studies in a Growing Industry Segment
October 04, 2021
Tickers
LGVN
From Benzinga
EXCLUSIVE: Longeveron Announces Biomarker Analysis Data From Mid-Stage Study Of Anti-Aging Cell Therapy Candidate
September 29, 2021
Tickers
LGVN
From Benzinga
Heart Hope: Announcing the Encouraging Results of a Cell-Therapy Clinical Study by Longeveron
September 15, 2021
From Benzinga
Longeveron Announces Final Results of Phase 1 Clinical Study of Lomecel-B Injection in Hypoplastic Left Heart Syndrome Patients
September 09, 2021
Tickers
LGVN
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 09, 2021
From Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Cell Therapy Meets Primary Safety Endpoint In Phase 1 Rare Congenital Heart Disease Study
September 09, 2021
Tickers
LGVN
From Benzinga
From Benzinga
From Benzinga
From Benzinga
60 Biggest Movers From Yesterday
August 17, 2021
From Benzinga
38 Stocks Moving In Monday's Mid-Day Session
August 16, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Monday
August 16, 2021
From Benzinga
From InvestorPlace
24 Stocks Moving in Monday's Pre-Market Session
August 16, 2021
From Benzinga
78 Biggest Movers From Friday
August 16, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 13, 2021
From Benzinga
53 Stocks Moving In Friday's Mid-Day Session
August 13, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Friday
August 13, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.